Bone repair with raloxifene and bioglass nanoceramic composite in animal experiment

Connect Tissue Res. 2018 Dec;59(sup1):97-101. doi: 10.1080/03008207.2018.1430143.

Abstract

Objective: This study proposes to evaluate, by means of microtomographic analysis, the topical potential of raloxifene combined with BioGran® through the sonochemical method in the repair of critical bone defects in the calvaria of rats. The hypothesis was that the homogenization of Raloxifene to Biogran at the 20% concentration would improve the bone repair at the grafted site.

Materials and methods: A 5-mm calvaria bone defect was induced in three groups: CTR (100% BioGran®); RAL10 (90% BioGran® and 10% raloxifene), and RAL20 (80% BioGran® and 20% raloxifene). The animals were euthanized after 30 days and the microCT analysis was then performed to evaluate the parameters bone volume (BV), bone volume percentage (BV/TV), trabecular bone thickness (Tb.Th), and the separation and number of trabeculae (Tb.Sp and Tb.N). The obtained results were compared using ANOVA and Tukey test (p < 0.05).

Results: The best results were found for the CTR and RAL20 groups, in which the BV, BV/TV, Tb.Sp, and Tb.N parameters were statistically significant in comparison with RAL10 (p < 0.05).

Conclusions: In view of the results obtained in this experiment, we can conclude that BioGran® alone or in an 80/20 mass concentration with raloxifene can lead to favorable bone formation.

Keywords: Bioglass; Biomaterials; Calvaria; Raloxifene; in vivo experiment; osteoporosis; raloxifene.

MeSH terms

  • Animals
  • Bone Density / drug effects*
  • Bone Regeneration / drug effects*
  • Ceramics* / chemistry
  • Ceramics* / pharmacology
  • Male
  • Nanocomposites* / chemistry
  • Nanocomposites* / therapeutic use
  • Raloxifene Hydrochloride* / chemistry
  • Raloxifene Hydrochloride* / pharmacology
  • Rats
  • Rats, Wistar
  • Skull* / injuries
  • Skull* / metabolism
  • Skull* / pathology

Substances

  • Bioglass
  • Raloxifene Hydrochloride